Paul Hartmann (PHH2) Stock Overview
Manufactures and sells medical and care products in Germany, the rest of Europe, the Middle East, Africa, Asia and Pacific region, and the Americas. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
PHH2 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
Paul Hartmann AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €208.00 |
| 52 Week High | €250.00 |
| 52 Week Low | €200.00 |
| Beta | 0.49 |
| 1 Month Change | 2.97% |
| 3 Month Change | -3.26% |
| 1 Year Change | -16.13% |
| 3 Year Change | 2.46% |
| 5 Year Change | -43.63% |
| Change since IPO | 74.45% |
Recent News & Updates
There May Be Reason For Hope In Paul Hartmann's (FRA:PHH2) Disappointing Earnings
The market for Paul Hartmann AG's ( FRA:PHH2 ) shares didn't move much after it posted weak earnings recently. We did...Paul Hartmann (FRA:PHH2) Has Affirmed Its Dividend Of €8.00
Paul Hartmann AG ( FRA:PHH2 ) will pay a dividend of €8.00 on the 6th of May. This means the annual payment is 3.3% of...Recent updates
Shareholder Returns
| PHH2 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | -0.5% | -1.1% | 2.4% |
| 1Y | -16.1% | -26.4% | 3.9% |
Return vs Industry: PHH2 exceeded the German Medical Equipment industry which returned -25.7% over the past year.
Return vs Market: PHH2 underperformed the German Market which returned 3.3% over the past year.
Price Volatility
| PHH2 volatility | |
|---|---|
| PHH2 Average Weekly Movement | 2.5% |
| Medical Equipment Industry Average Movement | 6.2% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in DE Market | 13.2% |
| 10% least volatile stocks in DE Market | 2.8% |
Stable Share Price: PHH2 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: PHH2's weekly volatility (3%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1818 | 10,066 | Britta Fuenfstueck | hartmann.info |
Paul Hartmann AG manufactures and sells medical and care products in Germany, the rest of Europe, the Middle East, Africa, Asia and Pacific region, and the Americas. The company operates through three segments: Wound Care, Incontinence Management, and Infection Management. It offers absorbent underwear, incontinence pads and pants, and fixation pants; medical skincare products; wound management products, such as hydro active wound and silicone SAP dressings, post-op dressings, nature care, adhesive fixation, non-adhesive fixation, gauze, sponges/tamponades, contact layers, absorption pads, cotton, and negative pressure wound therapy; compression, universal, zinc paste, and padding bandages; and hands, skin, surface, instruments, and equipment disinfection and hygiene products.
Paul Hartmann AG Fundamentals Summary
| PHH2 fundamental statistics | |
|---|---|
| Market cap | €738.76m |
| Earnings (TTM) | €61.21m |
| Revenue (TTM) | €2.46b |
Is PHH2 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PHH2 income statement (TTM) | |
|---|---|
| Revenue | €2.46b |
| Cost of Revenue | €1.02b |
| Gross Profit | €1.43b |
| Other Expenses | €1.37b |
| Earnings | €61.21m |
Last Reported Earnings
Dec 31, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | 17.23 |
| Gross Margin | 58.34% |
| Net Profit Margin | 2.49% |
| Debt/Equity Ratio | 22.4% |
How did PHH2 perform over the long term?
See historical performance and comparisonDividends
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/06/17 10:38 |
| End of Day Share Price | 2026/06/17 00:00 |
| Earnings | 2025/12/31 |
| Annual Earnings | 2025/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Paul Hartmann AG is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.